Katya Corado, MD

Health Sciences Associate Clinical Professor

Dr. Corado is an investigator at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center and Health Sciences Associate Clinical Professor of Medicine at UCLA. She is an Infectious Disease physician who is part of the Division of HIV at Harbor-UCLA. She also is Clinical Lead for HIV Services at the Ambulatory Care Network at DHS.

Her research has mainly focused on pre-exposure prophylaxis (PrEP) in HIV, QI projects within DHS surrounding linkage and care of patients at high risk for HIV and STI, and was involved with ACTIV-2 during the COVID-19 pandemic studying new medications for the outpatient treatment of COVID-19.

Areas of Expertise
  • AHIV
  • PrEP
  • Linkage to Care
Education
  • Undergrad: Claremont McKenna College
  • Medical School: David Geffen School of Medicine at UCLA
Publications

Notable recent publications:

  • Corado, K et al. Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 and BMS-986413 Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 trial. Pathog Immun 2024;9:138-155. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093219/
A list of Dr. Corado’s publications can be found here